We are committed to state-of-the-art on-going research which will advance the care of patients with rheumatic disease, now and in the future.
Our Division of Rheumatology is a world leader in the clinical care of patients with some of the most complex of all medical diseases, including rheumatoid arthritis, lupus, scleroderma, and vasculitis. The Division's researchers have made important contributions to development of novel therapies that are improving patient outcomes every day. Learn more about the HSS Research Institute and our active Clinical Trials and Studies or see our recent publications below.
Recent Publications from HSS Rheumatologists and Scientists
Vaccination In Rheumatic Disease
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Anne R. Bass, Eliza Chakravarty, Elie A. Akl, Clifton O. Bingham, et al in Arthritis Care & Research | January 2023
"Find out how to manage your patients’ immunosuppressive medications at the time of vaccination, and lots more, in the new 2022 ACR Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases." — Anne R. Bass, MD
Lupus And Assisted Reproduction
Infertility in Systemic Lupus Erythematosus: What Rheumatologists Need to Know in a New Age of Assisted Reproductive Technology. Bessie Stamm, Medha Barbhaiya, Caroline Siegel, Sarah Lieber, Michael Lockshin, Lisa Sammaritano in Lupus Science & Medicine | December 2022
"Review the latest on infertility risk for patients with systemic lupus erythematosus - and how to guide patients towards appropriate and safe use of the newest assisted reproductive technologies." — Lisa R. Sammaritano, MD
Covid-19 Vaccination And Rituximab
B-cell Reconstitution is Associated with COVID-19 Booster Vaccine Responsiveness in Previously Seronegative Rituximab Treated Patients. Kaitlin Schultz, Deanna Jannat-Khah, Robert Spiera in The Journal of Rheumatology | December 2022
"What factors are associated with COVID-19 booster vaccine responsiveness in rituximab treated rheumatic disease patients that failed to seroconvert following the first two doses of the vaccine?" — Kaitlin Schultz, BA
Immune Checkpoint Inhibitor Induced Arthritis And Pmr
Identification of Outcome Domains in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Polymyalgia Rheumatica: A Scoping Review by the OMERACT irAE Working Group. Nilasha Ghosh, Nina Couette, Wouter H. van Binsbergen, Sophia C. Weinmann, Bridget Jivanelli, Beverley Shea, Anne R. Bass et al in Seminars in Arthritis and Rheumatism | October 2022
"The Omeract irAE Working Group presents a compilation of important outcome domains in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and PMR that will help inform a core set of domains for future clinical trials." — Nilasha Ghosh, MD, MS, RhUSMS
Evaluating Cognitive Biases In Clinical Reasoning In Medical Students
Using an Experiential Learning Model to Teach Clinical Reasoning Theory and Cognitive Bias: An Evaluation of a First-Year Medical Student Curriculum. Justin J. Choi, Jeanie Gribben, Myriam Lin, Erika L. Abramson, Juliet Aizer in Medical Education Online | December 2022
"Learn how we created valuable experiences for medical students to develop their knowledge, skills, and self-efficacy related to clinical reasoning." — Juliet Aizer, MD, MPH
Disparities In Total Joint Arthroplasty
Racial and Ethnic Disparities in Total Joint Arthroplasty Care: A Contemporary Systematic Review and Meta-Analysis. Samuel S. Rudisill, Nathan H. Varady, Aseal Birir, Susan M. Goodman, Michael L. Parks, Troy B. Amen in The Journal of Arthroplasty | January 2023
"This systematic review and meta-analysis revealed that there are significant racial and ethnic disparities in TJA utilizations and outcomes, with minority patients often demonstrating lower rates of utilizations and worse postoperative outcomes than white patients. Learn more with the link above." — Susan M. Goodman, MD